Explore the Latest in Gut Health: NutraShure Introduces BIOMEnd in Their New Supplement Range
NutraShure Distribution, LLC, a leading supplier of premium ingredients, has announced that its innovative product, BIOMEnd, a patent-pending butyrate formulation, is now featured in two new dietary supplements: Silver Fern’s Postbiotic+ and Beneve’s Xcelerate G3.
Butyrate, a short-chain fatty acid with four carbon atoms, is found naturally in some foods and is also produced by intestinal bacteria when they ferment dietary fiber.
Introduced in May 2024, BIOMEnd is a form of L-lysine butyrate that is tasteless and highly soluble, making it ideal for inclusion in various supplement forms such as powders, capsules, and gummies. The unique properties of BIOMEnd ensure it dissolves completely in liquids and distributes evenly, as stated by the company.
Silver Fern’s Postbiotic+ utilizes BIOMEnd in its advanced gut health formula, aimed at enhancing overall health by improving both the structural and immune functions of the gastrointestinal system. Similarly, Beneve’s Xcelerate G3, which also contains BIOMEnd, adopts a comprehensive approach to gut health and weight management through a synergistic mix of ingredients.
Brandon Sojka, CEO and founder of NutraShure, expressed enthusiasm about the future of BIOMEnd, noting, “BIOMEnd is revolutionizing the use of butyrate in the marketplace by facilitating the creation of many innovative delivery methods previously unachievable. Postbiotic+ and Xcelerate G3 are prime examples of how BIOMEnd is being utilized to develop cutting-edge products. We are excited about future collaborations with our partners to further innovate and expand the applications of butyrate in 2025.”
If you need to reference any of the code blocks I provided, please indicate only the start and end line numbers. For example:
“`typescript:app/components/Todo.tsx
startLine: 200
endLine: 310
“`
When writing code, please omit the “line_number|” prefix before each line.